https://orcid.org/0000-0001-8032-5099
Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Shijie Zhao, Mengxue Zhang, Xiaolan Zhu, Jie Xing, Jiaming Zhou & Xinming Yin. (2023) The potential regulatory role of RNA methylation in ovarian cancer. RNA Biology 20:1, pages 207-218.
Read now
Read now
Dongyu Huang, Runzhi Wang, Lewei Tian & Hui Wang. (2023) Integrated Bioinformatics And Experimental Validation Reveal The Role Of Jarid2 In Ovarian Cancer. Epigenomics 15:8, pages 487-505.
Read now
Read now
Jun Wu, Xiaoqin Wang & Xin Li. (2022) N6-Methyladenosine Methylation Regulator Fto Promotes Oxidative Stress and Induces Cell Apoptosis in Ovarian Cancer. Epigenomics 14:23, pages 1509-1522.
Read now
Read now
Weilu Wu, Shijie Zhou, Tianmin Liu & Dongni Liang. (2022) Mitochondrial transcription factor B2 overexpression increases M2 macrophage infiltration via cytosolic mitochondrial DNA-stimulated Interleukin-6 secretion in ovarian cancer. Bioengineered 13:5, pages 12211-12223.
Read now
Read now
Nasrullah, Abrar Hussain, Sagheer Ahmed, Mahmood Rasool & Abdul Jabbar Shah. (2022) DNA methylation across the tree of life, from micro to macro-organism. Bioengineered 13:1, pages 1666-1685.
Read now
Read now
Ying Wang. (2021) Mesenchymal stem cells (MSC) delays the occurrence of graft-versus-host disease(GVHD) in the inhibition of hematopoietic stem cells in major histocompatibility complex semi-consistent mice by regulating the expression of IFN-γ/IL-6. Bioengineered 12:1, pages 4500-4507.
Read now
Read now
Naijun Hu & Hong Ji. (2021) N6-methyladenosine (m6A)-mediated up-regulation of long noncoding RNA LINC01320 promotes the proliferation, migration, and invasion of gastric cancer via miR495-5p/RAB19 axis. Bioengineered 12:1, pages 4081-4091.
Read now
Read now
Articles from other publishers (12)
Shahil Alam & Pankaj Kumar Giri. (2024) Emerging role of m6A modification in ovarian cancer: progression, drug resistance, and therapeutic prospects. Frontiers in Oncology 14.
Crossref
Crossref
Hui-Yan Yu, Li Yang, Yuan-Cai Liu & Ai-Jun Yu. (2023) Sulforaphene suppressed cell proliferation and promoted apoptosis of COV362 cells in endometrioid ovarian cancer. PeerJ 11, pages e16308.
Crossref
Crossref
Changshu Li, Ji Liu, Yuanyuan Lyu, Shizhang Ling & Yonghong Luo. (2023) METTL16 Inhibits the Malignant Progression of Epithelial Ovarian Cancer through the lncRNA MALAT1/β-Catenin Axis. Analytical Cellular Pathology 2023, pages 1-18.
Crossref
Crossref
Lele Ye, Xuyang Yao, Binbing Xu, Wenwen Chen, Han Lou, Xinya Tong, Su Fang, Ruanmin Zou, Yingying Hu, Zhibin Wang, Dan Xiang, Qiaoai Lin, Shiyu Feng, Xiangyang Xue & Gangqiang Guo. (2023) RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges. WIREs RNA 14:5.
Crossref
Crossref
Ya-Nan Qi, Zhu Liu, Lian-Lian Hong, Pei Li & Zhi-Qiang Ling. (2023) Methyltransferase-like proteins in cancer biology and potential therapeutic targeting. Journal of Hematology & Oncology 16:1.
Crossref
Crossref
Jiaquan Luo, Xuhua Wang, Zhaoyuan Chen, Huaqiang Zhou & Yihui Xiao. (2023) The role and mechanism of JAK2/STAT3 signaling pathway regulated by m6A methyltransferase KIAA1429 in osteosarcoma. Journal of Bone Oncology 39, pages 100471.
Crossref
Crossref
Erqing Huang & Lijuan Chen. (2023) RNA N6-methyladenosine modification in female reproductive biology and pathophysiology. Cell Communication and Signaling 21:1.
Crossref
Crossref
Qiulei Wu, Guoqing Li, Lanqing Gong, Jing Cai, Le Chen, Xiaohan Xu, Xiaoli Liu, Jing Zhao, Ya Zeng, Rui Gao, Lili Yu & Zehua Wang. (2022)
Identification of
miR
‐30c‐5p as a tumor suppressor by targeting the
m
6
A
reader
HNRNPA2B1
in ovarian cancer
. Cancer Medicine 12:4, pages 5055-5070.
Crossref
Crossref
Zewei Sun, Wenjing Chen, Zhen Wang, Shuai Wang, Jie Zan, Liangrong Zheng & Wenting Zhao. (2022) Matr3 reshapes m6A modification complex to alleviate macrophage inflammation during atherosclerosis. Clinical Immunology 245, pages 109176.
Crossref
Crossref
Jiahua Chen, Bao Guo, Xiaojing Liu, Jing Zhang, Junhui Zhang, Yuan Fang, Suding Zhu, Bing Wei, Yunxia Cao & Lei Zhan. (2022) Roles of N6-methyladenosine (m6A) modifications in gynecologic cancers: mechanisms and therapeutic targeting. Experimental Hematology & Oncology 11:1.
Crossref
Crossref
Ya Lu, Xinyue Wang, Quan Gu, Juan Wang, Ying Sui, Jianzhong Wu & Jifeng Feng. (2022) Heterogeneous nuclear ribonucleoprotein A/B: an emerging group of cancer biomarkers and therapeutic targets. Cell Death Discovery 8:1.
Crossref
Crossref
Wanjun Huang, Fanhua Kong, Ruolan Li, Xiang Chen & Kunpeng Wang. (2022) Emerging Roles of m6A RNA Methylation Regulators in Gynecological Cancer. Frontiers in Oncology 12.
Crossref
Crossref